Neil M. Kurtz, M.D. is President and Chief Executive Officer of Golden Living. Prior to joining the company in 2008, he was President and Chief Executive Officer and a member of the board of directors of TorreyPines Therapeutics, Inc. for six years.
Before that, Dr. Kurtz co-founded Worldwide Clinical Trials, a contract research organization, where he held the positions of President and Chief Executive Officer until its acquisition by United Health Group, or UHG, in September 1999.
After the acquisition, Dr. Kurtz became President of Ingenix Pharmaceutical Services, a division of UHG, and also served as a member of the UHG Executive Board until joining TorreyPines. Dr. Kurtz’s career includes senior positions with Boots Pharmaceuticals, Bayer Corporation, Bristol-Myers Squibb, and Merck.
In addition to Golden Living, he currently serves on the boards of three companies, NeurogesX, a specialty pharmaceutical company, Stemedica, a company exploring the use of adult stem cell for treating serious medical conditions, and Medidata Solutions, a global provider of data management services. In addition, Dr. Kurtz has consulted to more than a dozen pharmaceutical companies and was a member of the faculty in the Department of Psychiatry at the University of Connecticut from 1984 to 1988 and the University of California, Los Angeles from July 1980 to 1981.
Dr. Kurtz earned a Bachelor of Arts Degree in Psychology from New York University and a Medical Doctorate Degree from the Medical College of Wisconsin, Milwaukee.